TRINITY BIOTECH PLC's ticker is TRIB and the CUSIP is 896438306. A total of 37 filers reported holding TRINITY BIOTECH PLC in Q1 2021. The put-call ratio across all filers is 0.89 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $12 | -99.9% | 12,381 | -15.3% | 0.00% | +100.0% |
Q3 2022 | $16,000 | -60.0% | 14,625 | -61.4% | 0.00% | -66.7% |
Q1 2022 | $40,000 | -64.9% | 37,926 | +26.9% | 0.00% | -75.0% |
Q4 2020 | $114,000 | +123.5% | 29,898 | +17.1% | 0.01% | +33.3% |
Q3 2020 | $51,000 | -62.2% | 25,538 | -24.4% | 0.01% | +12.5% |
Q3 2018 | $135,000 | – | 33,771 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACK Asset Management | 928,000 | $10,616,000 | 4.44% |
GOLDMAN CAPITAL MANAGEMENT INC | 350,961 | $4,015,000 | 2.86% |
Paradice Investment Management LLC | 992,235 | $11,351,000 | 2.07% |
Centaur Capital | 77,500 | $887,000 | 1.33% |
Adirondack Funds | 302,305 | $3,458,000 | 1.33% |
Adirondack Research & Management Inc. | 302,305 | $3,458,000 | 1.33% |
RK Capital | 565,472 | $6,469,000 | 1.18% |
Lyon Street Capital, LLC | 140,943 | $1,612,000 | 1.17% |
Benchmark Capital Advisors | 89,941 | $1,029,000 | 0.84% |
KEANE CAPITAL MANAGEMENT INC | 55,045 | $630,000 | 0.83% |